Article(id=1327672702162285455, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672638123651498, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.07.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1631030400000, receivedDateStr=2021-09-08, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471439160, onlineDateStr=2026-11-12, pubDate=1657382400000, pubDateStr=2022-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471439160, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471439160, creator=13701087609, updateTime=1794471439160, updator=13701087609, issue=Issue{id=1327672638123651498, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='7', pageStart='925', pageEnd='1080', issueExtLink='null', onlineDate='null', pubDate='1657382400000', pubDateStr='2022-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471423893, creator='13701087609', updateTime=1794472192126, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675861089760223, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672638123651498, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675861093954528, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672638123651498, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=953, endPage=961, ext={EN=ArticleExt(id=1327672702409749392, articleId=1327672702162285455, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Co-amorphous Drugs, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

In recent years, the co-amorphous drug formulations have gradually become a new type of drug delivery system with great potential. Co-amorphous drug formulations can improve the stability of amorphous drugs and improve the solubility and dissolution of poorly water-soluble drugs, thereby potentially improving their bioavailability and therapeutic effects. This paper reviews co-amorphous drugs from the perspectives of preparation methods, physicochemical properties, physical stability, and in vitro performance, and clarifieds the in vivo advantages of co-amorphous drugs through a review of the pharmacokinetics of several classic drugs. In particular, the advantages of co-amorphous drugs in theory, preparation technology, and physicochemical properties are discussed to provide a reference for the further development of high-quality co-amorphous drug formulations.

, authors=Xiaoping FANG, Yi HU, Shan LU, Yan CAO*, authorsList=Xiaoping FANG, Yi HU, Shan LU, Yan CAO, authorCompany=null, correspAuthors=Yan CAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327672702875317137, articleId=1327672702162285455, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=共无定形药物的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

近年来,共无定形药物制剂逐渐成为一种很有潜力的新型药物传递系统。共无定形药物制剂可提高无定形态药物的稳定性,改善难溶性药物的溶解度和溶出度,从而潜在提高生物利用度和治疗效果。本研究从制备方法、理化特性、物理稳定性和体外性能的角度对共无定形药物进行了综述,并通过几个经典药物的药代动力学案例回顾,阐明了共无定形药物的体内优势。特别是,重点从理论基础、制备技术、理化性质等方面对共无定形药物的优势进行了探讨,为进一步开发高质量共无定形药物制剂提供参考。

, authors=方晓萍, 胡义, 卢山, 曹艳*, authorsList=方晓萍, 胡义, 卢山, 曹艳, authorCompany=null, correspAuthors=曹艳, authorNote=

方晓萍(1998—),女,硕士研究生,专业方向:中药制剂及新剂型、新技术、新材料。

, correspAuthorsNote=
曹艳(1975—),女,教授,从事中药制剂及新剂型、新技术、新材料的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=uTCIYLDcgzuVR0+AIIKHeg==, magXml=utrJnUmJU1HG66VIGqkBrg==, pdfUrl=null, pdf=4E+vLSHUzUxDRl4V/Iy2XQ==, pdfFileSize=1492559, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=fBXNQZjan+PVXXxUe1Evvg==, mapNumber=null, fund=null)}, authors=[Author(id=1327672705450619798, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672705530311576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705450619798, language=EN, stringName=Xiaoping FANG, firstName=Xiaoping, middleName=null, lastName=FANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672705610003353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705450619798, language=CN, stringName=方晓萍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=湖北中医药大学药学院,湖北 武汉 430065, bio={"content":"

方晓萍(1998—),女,硕士研究生,专业方向:中药制剂及新剂型、新技术、新材料。

"}, bioImg=null, bioContent=

方晓萍(1998—),女,硕士研究生,专业方向:中药制剂及新剂型、新技术、新材料。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])]), Author(id=1327672705719055259, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672705794552733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705719055259, language=EN, stringName=Yi HU, firstName=Yi, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672705861661598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705719055259, language=CN, stringName=胡义, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=湖北中医药大学药学院,湖北 武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])]), Author(id=1327672705928770464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672706008462242, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705928770464, language=EN, stringName=Shan LU, firstName=Shan, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672706092348323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705928770464, language=CN, stringName=卢山, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=湖北中医药大学药学院,湖北 武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])]), Author(id=1327672706163651493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=caoyan1999@hbtcm.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672706234954663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672706163651493, language=EN, stringName=Yan CAO, firstName=Yan, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672706289480616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672706163651493, language=CN, stringName=曹艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=湖北中医药大学药学院,湖北 武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])])], keywords=[Keyword(id=1327672706394338217, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=EN, orderNo=1, keyword=co-amorphous drug), Keyword(id=1327672706457252778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=EN, orderNo=2, keyword=poorly water-soluble drug), Keyword(id=1327672706532750251, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=EN, orderNo=3, keyword=physicochemical property), Keyword(id=1327672706595664812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=EN, orderNo=4, keyword=physical stability), Keyword(id=1327672706654385069, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=CN, orderNo=1, keyword=共无定形药物), Keyword(id=1327672706708911022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=CN, orderNo=2, keyword=难溶性药物), Keyword(id=1327672706784408495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=CN, orderNo=3, keyword=理化特性), Keyword(id=1327672706843128752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, language=CN, orderNo=4, keyword=物理稳定性)], refs=[Reference(id=1327672706922820529, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CARNERO A.High throughput screening in drug discovery[J].Clin Transl Oncol, 2006, 8(7): 482-490., articleTitle=null, refAbstract=null), Reference(id=1327672706985735090, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=OLIVEIRA V D S, DE ALMEIDA A S, ALBUQUERQUE I D S, et al.Therapeutic applications of solid dispersions for drugs and new molecules: in vitro and in vivo activities [J].Pharmaceutics, 2020, 12(10): 933., articleTitle=null, refAbstract=null), Reference(id=1327672707044455347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=王礼丽,高紫尧,刘书妤.药物共晶的研究新进展[J].中国医药工业杂志,2021,52(7):881-890., articleTitle=null, refAbstract=null), Reference(id=1327672707111564212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=PELTONEN L, STRACHAN C J.Degrees of order: a comparison of nanocrystal and amorphous solids for poorly soluble drugs [J].Int J Pharm, 2020, 586: 119492., articleTitle=null, refAbstract=null), Reference(id=1327672707170284469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU C, WANG H.Thermodynamic Descriptions of the Co-Zr and Co-Fe-Zr systems [J].J Phase Equilib Diff,2021, 42: 77-90., articleTitle=null, refAbstract=null), Reference(id=1327672707262559158, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=POLAKA S, DESAI N, KSHIRSAGAR B, et al.Chapter 12 - Revamping the pharmacokinetics of poorly soluble drugs using different formulations [M]// TEKADE R K.Biopharmaceutics and pharmacokinetics considerations.Volume 1 in advances in pharmaceutical product development and research.[S.l.]: Academic Press, 2021: 387-413., articleTitle=null, refAbstract=null), Reference(id=1327672707329668023, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=PAUDWAL G, RAWAT N, GUPTA R, et al.Recent advances in solid dispersion technology for efficient delivery of poorly water-soluble drugs [J].Curr Pharm Des, 2019,25(13): 1524-1535., articleTitle=null, refAbstract=null), Reference(id=1327672707421942712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=SOSNA T, MIKESKA M, DUTKO O, et al.Micronization of ibuprofen particles using supercritical fluid technology[J].J Nanosci Nanotechnol, 2019, 19(5): 2814-2820., articleTitle=null, refAbstract=null), Reference(id=1327672707505828793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN J, WEI Y, LU Y, et al.Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update [J].Expert Opin Drug Deliv, 2020, 17(10):1411-1435., articleTitle=null, refAbstract=null), Reference(id=1327672707610686394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LAITINEN R, LÖBMANN K, STRACHAN C J, et al.Emerging trends in the stabilization of amorphous drugs[J].Int J Pharm, 2013, 453(1): 65-79., articleTitle=null, refAbstract=null), Reference(id=1327672707690378171, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI Q, MOINUDDIN S M, CAI T.Advances in coamorphous drug delivery systems [J].Acta Pharm Sin B,2019, 9(1): 19-35., articleTitle=null, refAbstract=null), Reference(id=1327672707786847164, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=AUCAMP M, MILNE M.The physical stability of drugs linked to quality-by-design (QbD) and in-process technology(PAT) perspectives [J].Eur J Pharm Sci, 2019, 139:105057., articleTitle=null, refAbstract=null), Reference(id=1327672707862344637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=PAS T, BERGONZI A, MICHIELS E, et al.Preparation of amorphous solid dispersions by cryomilling: chemical and physical concerns related to active pharmaceutical ingredients and carriers [J].Mol Pharm, 2020, 17(3): 1001-1013., articleTitle=null, refAbstract=null), Reference(id=1327672707937842110, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU W, FAN W, ZHANG X, et al.Sustained-release solid dispersion of high-melting-point and insoluble resveratrol prepared through hot melt extrusion to improve its solubility and bioavailability [J].Molecules, 2021, 26(16): 4982., articleTitle=null, refAbstract=null), Reference(id=1327672708059476927, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HU Y, JIANG C, LI B, et al.A novel lurasidone hydrochloride–shikimic acid co-amorphous system formed by hydrogen-bonding interaction with the retained pH-dependent solubility behavior [J].CrystEngComm, 2020,22(35): 5841-5853., articleTitle=null, refAbstract=null), Reference(id=1327672708160140224, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=QIAN S, LI Z, HENG W, et al.Charge-assisted intermolecular hydrogen bond formed in coamorphous system is important to relieve the pH-dependent solubility behavior of lurasidone hydrochloride [J].RSC Adv, 2016,6(108): 106396-106412., articleTitle=null, refAbstract=null), Reference(id=1327672708231443393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LÖBMANN K, GROHGANZ H, LAITINEN R, et al.Amino acids as co-amorphous stabilizers for poorly water soluble drugs--part 1: preparation, stability and dissolution enhancement [J].Eur J Pharm Biopharm, 2013, 85(3 Pt B):873-881., articleTitle=null, refAbstract=null), Reference(id=1327672708294357954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU S, GAO H, BABU S, et al.Co-amorphous formation of high-dose zwitterionic compounds with amino acids to improve solubility and enable parenteral delivery [J].Mol Pharm, 2018, 15(1): 97-107., articleTitle=null, refAbstract=null), Reference(id=1327672708361466819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=D'ANGELO A, EDGAR B, HURT A P, et al.Physicochemical characterisation of three-component co-amorphous systems generated by a melt-quench method [J].J Therm Anal Calorim, 2018, 134(1): 381-390., articleTitle=null, refAbstract=null), Reference(id=1327672708420187076, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SU M, XIA Y, SHEN Y, et al.A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide[J].RSC Adv, 2020, 10(1): 565-583., articleTitle=null, refAbstract=null), Reference(id=1327672708516656069, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=KILPELÄINEN T, PAJULA K, ERVASTI T, et al.Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems [J].Eur J Pharm Biopharm, 2020, 155: 49-54., articleTitle=null, refAbstract=null), Reference(id=1327672708592153542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG M, LIU S, JIA L, et al.Exploring the physical stability of three nimesulide-indomethacin co-amorphous systems from the perspective of molecular aggregates [J].Eur J Pharm Sci, 2020, 147: 105294., articleTitle=null, refAbstract=null), Reference(id=1327672708655068103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG F, AALTONEN J, TIAN F, et al.Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin [J].Eur J Pharm Biopharm, 2009, 71(1): 64-70., articleTitle=null, refAbstract=null), Reference(id=1327672708717982664, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=PARK H, JIN SEO H, HONG S H, et al.Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: influence of molar ratio and preparation methods [J].Int J Pharm, 2020, 581: 119232., articleTitle=null, refAbstract=null), Reference(id=1327672708789285833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAMBERS LI, GROHGANZ H, PALMELUND H, et al.Predictive identification of co-formers in co-amorphous systems [J].Eur J Pharm Sci, 2021, 157: 105636., articleTitle=null, refAbstract=null), Reference(id=1327672710458618827, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MOINUDDIN S M, SHI Q, TAO J, et al.Enhanced physical stability and synchronized release of febuxostat and indomethacin in coamorphous solids [J].AAPS PharmSciTech, 2020, 21(2): 41., articleTitle=null, refAbstract=null), Reference(id=1327672710542504909, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=HU Y, GUO Y, LI B, et al.Influence of the pKa value of cinnamic acid and P-hydroxycinnamic acid on the solubility of a lurasidone hydrochloride-based coamorphous system[J].ACS Omega, 2021, 6(4): 3106-3119., articleTitle=null, refAbstract=null), Reference(id=1327672710618002382, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=WU W, GROHGANZ H, RADES T, et al.Comparison of co-former performance in co-amorphous formulations: single amino acids, amino acid physical mixtures, amino acid salts and dipeptides as co-formers [J].Eur J Pharm Sci, 2021,156: 105582., articleTitle=null, refAbstract=null), Reference(id=1327672710714471375, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=RUSSO M G, BALDONI H A, DÁVILA Y A, et al.Rational design of a famotidine-ibuprofen coamorphous system: an experimental and theoretical study [J].J Phys Chem B, 2018, 122(37): 8772-8782., articleTitle=null, refAbstract=null), Reference(id=1327672710882243536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH A, VAN DEN MOOTER G.Spray drying formulation of amorphous solid dispersions [J].Adv Drug Deliver Rev, 2016, 100: 27-50., articleTitle=null, refAbstract=null), Reference(id=1327672710940963793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y, GAO Y, DU X, et al.Combining co-amorphous-based spray drying with inert carriers to achieve improved bioavailability and excellent downstream manufacturability[J].Pharmaceutics, 2020, 12(11): 1063., articleTitle=null, refAbstract=null), Reference(id=1327672711016461266, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=HIRAKAWA Y, UEDA H, TAKATA Y, et al.Co-amorphous formation of piroxicam-citric acid to generate supersaturation and improve skin permeation [J].Eur J Pharm Sci, 2021,158: 105667., articleTitle=null, refAbstract=null), Reference(id=1327672711075181523, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=OJARINTA R, LERMINIAUX L, LAITINEN R.Spray drying of poorly soluble drugs from aqueous arginine solution [J].Int J Pharm, 2017, 532(1): 289-298., articleTitle=null, refAbstract=null), Reference(id=1327672711205204948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=BOURDET A, ARAUJO S, THIYAGARAJAN S, et al.Molecular mobility in amorphous biobased copolyesters obtained with 2,5- and 2,4-furandicarboxylate acid [J].Polymer, 2021, 213: 123225., articleTitle=null, refAbstract=null), Reference(id=1327672711293285333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=PHAN A D, THU THUY T T, KIM AN N T, et al.Molecular relaxations in supercooled liquid and glassy states of amorphous gambogic acid: dielectric spectroscopy, calorimetry, and theoretical approach [J].AIP Adv, 2020,10: 025128.., articleTitle=null, refAbstract=null), Reference(id=1327672711368782806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=YARLAGADDA D L, SAI KRISHNA ANAND V, NAIR A R, et al.Considerations for the selection of co-formers in the preparation of co-amorphous formulations [J].Int J Pharm, 2021, 602: 120649., articleTitle=null, refAbstract=null), Reference(id=1327672711435891671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=DENGALE S J, GROHGANZ H, RADES T, et al.Recent advances in co-amorphous drug formulations [J].Adv Drug Deliv Rev, 2016, 100: 116-125., articleTitle=null, refAbstract=null), Reference(id=1327672711532360664, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=QIAN S, HENG W, WEI Y, et al.Coamorphous lurasidone hydrochloride−saccharin with charge- assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior [J].Cryst Growth Des, 2015, 15(6): 2920-2928., articleTitle=null, refAbstract=null), Reference(id=1327672711658189785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN X, LI D, ZHANG H, et al.Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: a strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis [J].Int J Pharm, 2021, 606: 120894., articleTitle=null, refAbstract=null), Reference(id=1327672711825961946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=TIAN Y, LIU X, XU L, et al.Engineering crystallinity and oxygen vacancies of Co(II) oxide nanosheets for high performance and robust rechargeable Zn–air batteries [J].Adv Funct Mater, 2021, 31(20): 2101239., articleTitle=null, refAbstract=null), Reference(id=1327672711914042331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=梅丽,金方.固体分散体表征手段的研究进展[J].中国医药工业杂志,2014,45(8):782-788., articleTitle=null, refAbstract=null), Reference(id=1327672711989539804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=DAMPF S J, KORTER T M.Crystalline molecular standards for low-frequency vibrational spectroscopies [J].J Infrared Milli Terahz Waves, 2020, 41(11): 1284-1300., articleTitle=null, refAbstract=null), Reference(id=1327672712073425885, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=SZCZUREK J, RAMS-BARON M, KNAPIK-KOWALCZUK J, et al.Molecular dynamics, recrystallization behavior, and water solubility of the amorphous anticancer agent bicalutamide and its polyvinylpyrrolidone mixtures [J].Mol Pharm, 2017,14(4): 1071-1081., articleTitle=null, refAbstract=null), Reference(id=1327672712144729054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=CHMIEL K, KNAPIK-KOWALCZUK J, JURKIEWICZ K, et al.A new method to identify physically stable concentration of amorphous solid dispersions (I): case of flutamide + Kollidon VA64 [J].Mol Pharm, 2017, 14(10):3370-3380., articleTitle=null, refAbstract=null), Reference(id=1327672712253780959, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=FUNG M H, SURYANARAYANAN R.Effect of organic acids on molecular mobility, physical stability, and dissolution of ternary ketoconazole spray-dried dispersions[J].Mol Pharm, 2019, 16(1): 41-48., articleTitle=null, refAbstract=null), Reference(id=1327672712329278432, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=WILSON V R, LOU X, OSTERLING D J, et al.Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance [J].Sci Rep,2020, 10(1): 18535., articleTitle=null, refAbstract=null), Reference(id=1327672712387998689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=HU C, ZHANG F, FAN H.Evaluation of drug dissolution rate in co-amorphous and co-crystal binary drug delivery systems by thermodynamic and kinetic methods [J].AAPS PharmSciTech, 2021, 22(1): 21., articleTitle=null, refAbstract=null), Reference(id=1327672712446718946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=BEVERNAGE J, BROUWERS J, BREWSTER M E, et al.Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues [J].Int J Pharm, 2013,453(1): 25-35., articleTitle=null, refAbstract=null), Reference(id=1327672712505439203, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=KNAPIK-KOWALCZUK J, CHMIEL K, JURKIEWICZ K, et al.Physical stability and viscoelastic properties of co-amorphous ezetimibe/simvastatin system [J].Pharmaceuticals, 2019, 12(1): 40., articleTitle=null, refAbstract=null), Reference(id=1327672712555770852, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=FAEL H, DEMIREL A L.Tannic acid as a co-former in co-amorphous systems: enhancing their physical stability, solubility and dissolution behavior [J].Int J Pharm, 2020,581: 119284., articleTitle=null, refAbstract=null), Reference(id=1327672712627074021, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=HILDEBRAND J H, SCOTT R L.The solubility of nonelectrolytes (3rd ed)[M].New York: Dover Publications, 1964., articleTitle=null, refAbstract=null), Reference(id=1327672712694182886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=HANSEN C M.The three dimensional solubility parameter and solvent diffusion coefficient [M].Copenhagen: Danish Technical Press, 1967., articleTitle=null, refAbstract=null), Reference(id=1327672712752903143, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=PAJULA K, HYYRYLÄINEN J, KOISTINEN A, et al.Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS [J].Eur J Pharm Biopharm, 2020, 150: 43-49., articleTitle=null, refAbstract=null), Reference(id=1327672712815817704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=LÖBMANN K, STRACHAN C, GROHGANZ H, et al.Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions [J].Eur J Pharm Biopharm,2012, 81(1): 159-169., articleTitle=null, refAbstract=null), Reference(id=1327672712887120873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=DI R, LIU J, GROHGANZ H, et al.A multivariate approach for the determination of the optimal mixing ratio of the non-strong interacting co-amorphous system carvedilol-tryptophan [J].Molecules, 2021, 26(4): 801., articleTitle=null, refAbstract=null), Reference(id=1327672712954229738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=UEDA H, WU W, LÖBMANN K, et al.Application of a salt coformer in a co-amorphous drug system dramatically enhances the glass transition temperature: a case study of the ternary system carbamazepine, citric acid, and L-arginine[J].Mol Pharm, 2018, 15(5): 2036-2044., articleTitle=null, refAbstract=null), Reference(id=1327672713025532907, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=TUREK M, RÓŻYCKA-SOKOŁOWSKA E, KOPROWSKI M, et al.Role of hydrogen bonds in formation of co-amorphous valsartan/nicotinamide compositions of high solubility and durability with anti-hypertension and anti-COVID-19 potential [J].Mol Pharm, 2021, 18(5): 1970-1984., articleTitle=null, refAbstract=null), Reference(id=1327672713117807596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=HATANAKA Y, UCHIYAMA H, KADOTA K, et al.Improved solubility and permeability of both nifedipine and ketoconazole based on coamorphous formation with simultaneous dissolution behavior [J].J Drug Deliv Sci Tec, 2021, 65: 102715., articleTitle=null, refAbstract=null), Reference(id=1327672713184916461, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=FUNG M H, DEVAULT M, KUWATA K T, et al.Drug-excipient interactions: effect on molecular mobility and physical stability of ketoconazole-organic acid coamorphous systems [J].Mol Pharm, 2018, 15(3): 1052-1061., articleTitle=null, refAbstract=null), Reference(id=1327672713243636719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Z, SUN M, LIU T, et al.Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability[J].Asian J Pharm Sci, 2019, 14(1): 95-103., articleTitle=null, refAbstract=null), Reference(id=1327672713314939888, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=UEDA H, PETER BØTKER J, EDINGER M, et al.Formulation of co-amorphous systems from naproxen and naproxen sodium and in situ monitoring of physicochemical state changes during dissolution testing by Raman spectroscopy [J].Int J Pharm, 2020, 587: 119662., articleTitle=null, refAbstract=null), Reference(id=1327672715034604531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=UEDA H, MURANUSHI N, SAKUMA S, et al.A strategy for co-former selection to design stable co-amorphous formations based on physicochemical properties of non-steroidal inflammatory drugs [J].Pharm Res, 2016, 33(4):1018-1029., articleTitle=null, refAbstract=null), Reference(id=1327672715160433652, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=MOINUDDIN S M, RUAN S, HUANG Y, et al.Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: enhanced physical stability, dissolution and pharmacokinetic profile [J].Int J Pharm,2017, 532(1): 393-400., articleTitle=null, refAbstract=null), Reference(id=1327672715231736821, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG J, CHANG R, ZHAO Y, et al.Coamorphous loratadine-citric acid system with enhanced physical stability and bioavailability [J].AAPS PharmSciTech, 2017, 18(7):2541-2550., articleTitle=null, refAbstract=null), Reference(id=1327672715298845686, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=ZVONÍČEK V, SKOŘEPOVÁ E, DUŠEK M, et al.First crystal structures of pharmaceutical ibrutinib: systematic solvate screening and characterization [J].Cryst Growth Des, 2017, 17(6): 3116-3127., articleTitle=null, refAbstract=null), Reference(id=1327672715407897591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[66], rfOrder=65, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI X, SONG S, DING Z, et al.Improving the solubility, dissolution, and bioavailability of ibrutinib by preparing it in a coamorphous state with saccharin [J].J Pharm Sci, 2019,108(9): 3020-3028., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.07.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.07.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.07.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.07.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1657382400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
共无定形药物的研究进展
方晓萍 , 胡义 , 卢山 , 曹艳 *
中国医药工业杂志 | 综述 2022,53(7): 953-961
收起
收藏切换
中国医药工业杂志 |综述 2022 , 53 (7) : 953 -961
共无定形药物的研究进展
全屏
[Author(id=1327672705450619798, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672705530311576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705450619798, language=EN, stringName=Xiaoping FANG, firstName=Xiaoping, middleName=null, lastName=FANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672705610003353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705450619798, language=CN, stringName=方晓萍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=湖北中医药大学药学院,湖北 武汉 430065, bio={"content":"

方晓萍(1998—),女,硕士研究生,专业方向:中药制剂及新剂型、新技术、新材料。

"}, bioImg=null, bioContent=

方晓萍(1998—),女,硕士研究生,专业方向:中药制剂及新剂型、新技术、新材料。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])]), Author(id=1327672705719055259, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672705794552733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705719055259, language=EN, stringName=Yi HU, firstName=Yi, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672705861661598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705719055259, language=CN, stringName=胡义, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=湖北中医药大学药学院,湖北 武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])]), Author(id=1327672705928770464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672706008462242, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705928770464, language=EN, stringName=Shan LU, firstName=Shan, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672706092348323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672705928770464, language=CN, stringName=卢山, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=湖北中医药大学药学院,湖北 武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])]), Author(id=1327672706163651493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=caoyan1999@hbtcm.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672706234954663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672706163651493, language=EN, stringName=Yan CAO, firstName=Yan, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672706289480616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, authorId=1327672706163651493, language=CN, stringName=曹艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=湖北中医药大学药学院,湖北 武汉 430065, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672705282847634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, xref=null, ext=[AuthorCompanyExt(id=1327672705320596371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065), AuthorCompanyExt(id=1327672705349956500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672702162285455, companyId=1327672705282847634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=湖北中医药大学药学院,湖北 武汉 430065)])])]
方晓萍, 胡义, 卢山, 曹艳*
作者信息
  • 湖北中医药大学药学院,湖北 武汉 430065
通讯作者:
曹艳(1975—),女,教授,从事中药制剂及新剂型、新技术、新材料的研究。E-mail:
作者简介:

方晓萍(1998—),女,硕士研究生,专业方向:中药制剂及新剂型、新技术、新材料。

Research Progress of Co-amorphous Drugs
Xiaoping FANG, Yi HU, Shan LU, Yan CAO*
Affiliations
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065
出版时间: 2022-07-10 doi: 10.16522/j.cnki.cjph.2022.07.004
文章导航
收藏切换

近年来,共无定形药物制剂逐渐成为一种很有潜力的新型药物传递系统。共无定形药物制剂可提高无定形态药物的稳定性,改善难溶性药物的溶解度和溶出度,从而潜在提高生物利用度和治疗效果。本研究从制备方法、理化特性、物理稳定性和体外性能的角度对共无定形药物进行了综述,并通过几个经典药物的药代动力学案例回顾,阐明了共无定形药物的体内优势。特别是,重点从理论基础、制备技术、理化性质等方面对共无定形药物的优势进行了探讨,为进一步开发高质量共无定形药物制剂提供参考。

共无定形药物  /  难溶性药物  /  理化特性  /  物理稳定性

In recent years, the co-amorphous drug formulations have gradually become a new type of drug delivery system with great potential. Co-amorphous drug formulations can improve the stability of amorphous drugs and improve the solubility and dissolution of poorly water-soluble drugs, thereby potentially improving their bioavailability and therapeutic effects. This paper reviews co-amorphous drugs from the perspectives of preparation methods, physicochemical properties, physical stability, and in vitro performance, and clarifieds the in vivo advantages of co-amorphous drugs through a review of the pharmacokinetics of several classic drugs. In particular, the advantages of co-amorphous drugs in theory, preparation technology, and physicochemical properties are discussed to provide a reference for the further development of high-quality co-amorphous drug formulations.

co-amorphous drug  /  poorly water-soluble drug  /  physicochemical property  /  physical stability
方晓萍, 胡义, 卢山, 曹艳. 共无定形药物的研究进展. 中国医药工业杂志, 2022 , 53 (7) : 953 -961 . DOI: 10.16522/j.cnki.cjph.2022.07.004
Xiaoping FANG, Yi HU, Shan LU, Yan CAO. Research Progress of Co-amorphous Drugs[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (7) : 953 -961 . DOI: 10.16522/j.cnki.cjph.2022.07.004

参考文献 引证文献
排序方式:
[1]
CARNERO A.High throughput screening in drug discovery[J].Clin Transl Oncol, 2006, 8(7): 482-490.
[2]
OLIVEIRA V D S, DE ALMEIDA A S, ALBUQUERQUE I D S, et al.Therapeutic applications of solid dispersions for drugs and new molecules: in vitro and in vivo activities [J].Pharmaceutics, 2020, 12(10): 933.
[3]
王礼丽,高紫尧,刘书妤.药物共晶的研究新进展[J].中国医药工业杂志,2021,52(7):881-890.
[4]
PELTONEN L, STRACHAN C J.Degrees of order: a comparison of nanocrystal and amorphous solids for poorly soluble drugs [J].Int J Pharm, 2020, 586: 119492.
[5]
ZHOU C, WANG H.Thermodynamic Descriptions of the Co-Zr and Co-Fe-Zr systems [J].J Phase Equilib Diff,2021, 42: 77-90.
[6]
POLAKA S, DESAI N, KSHIRSAGAR B, et al.Chapter 12 - Revamping the pharmacokinetics of poorly soluble drugs using different formulations [M]// TEKADE R K.Biopharmaceutics and pharmacokinetics considerations.Volume 1 in advances in pharmaceutical product development and research.[S.l.]: Academic Press, 2021: 387-413.
[7]
PAUDWAL G, RAWAT N, GUPTA R, et al.Recent advances in solid dispersion technology for efficient delivery of poorly water-soluble drugs [J].Curr Pharm Des, 2019,25(13): 1524-1535.
[8]
SOSNA T, MIKESKA M, DUTKO O, et al.Micronization of ibuprofen particles using supercritical fluid technology[J].J Nanosci Nanotechnol, 2019, 19(5): 2814-2820.
[9]
HAN J, WEI Y, LU Y, et al.Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update [J].Expert Opin Drug Deliv, 2020, 17(10):1411-1435.
[10]
LAITINEN R, LÖBMANN K, STRACHAN C J, et al.Emerging trends in the stabilization of amorphous drugs[J].Int J Pharm, 2013, 453(1): 65-79.
[11]
SHI Q, MOINUDDIN S M, CAI T.Advances in coamorphous drug delivery systems [J].Acta Pharm Sin B,2019, 9(1): 19-35.
[12]
AUCAMP M, MILNE M.The physical stability of drugs linked to quality-by-design (QbD) and in-process technology(PAT) perspectives [J].Eur J Pharm Sci, 2019, 139:105057.
[13]
PAS T, BERGONZI A, MICHIELS E, et al.Preparation of amorphous solid dispersions by cryomilling: chemical and physical concerns related to active pharmaceutical ingredients and carriers [J].Mol Pharm, 2020, 17(3): 1001-1013.
[14]
ZHU W, FAN W, ZHANG X, et al.Sustained-release solid dispersion of high-melting-point and insoluble resveratrol prepared through hot melt extrusion to improve its solubility and bioavailability [J].Molecules, 2021, 26(16): 4982.
[15]
HU Y, JIANG C, LI B, et al.A novel lurasidone hydrochloride–shikimic acid co-amorphous system formed by hydrogen-bonding interaction with the retained pH-dependent solubility behavior [J].CrystEngComm, 2020,22(35): 5841-5853.
[16]
QIAN S, LI Z, HENG W, et al.Charge-assisted intermolecular hydrogen bond formed in coamorphous system is important to relieve the pH-dependent solubility behavior of lurasidone hydrochloride [J].RSC Adv, 2016,6(108): 106396-106412.
[17]
LÖBMANN K, GROHGANZ H, LAITINEN R, et al.Amino acids as co-amorphous stabilizers for poorly water soluble drugs--part 1: preparation, stability and dissolution enhancement [J].Eur J Pharm Biopharm, 2013, 85(3 Pt B):873-881.
[18]
ZHU S, GAO H, BABU S, et al.Co-amorphous formation of high-dose zwitterionic compounds with amino acids to improve solubility and enable parenteral delivery [J].Mol Pharm, 2018, 15(1): 97-107.
[19]
D'ANGELO A, EDGAR B, HURT A P, et al.Physicochemical characterisation of three-component co-amorphous systems generated by a melt-quench method [J].J Therm Anal Calorim, 2018, 134(1): 381-390.
[20]
SU M, XIA Y, SHEN Y, et al.A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide[J].RSC Adv, 2020, 10(1): 565-583.
[21]
KILPELÄINEN T, PAJULA K, ERVASTI T, et al.Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems [J].Eur J Pharm Biopharm, 2020, 155: 49-54.
[22]
WANG M, LIU S, JIA L, et al.Exploring the physical stability of three nimesulide-indomethacin co-amorphous systems from the perspective of molecular aggregates [J].Eur J Pharm Sci, 2020, 147: 105294.
[23]
ZHANG F, AALTONEN J, TIAN F, et al.Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin [J].Eur J Pharm Biopharm, 2009, 71(1): 64-70.
[24]
PARK H, JIN SEO H, HONG S H, et al.Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: influence of molar ratio and preparation methods [J].Int J Pharm, 2020, 581: 119232.
[25]
CHAMBERS LI, GROHGANZ H, PALMELUND H, et al.Predictive identification of co-formers in co-amorphous systems [J].Eur J Pharm Sci, 2021, 157: 105636.
[26]
MOINUDDIN S M, SHI Q, TAO J, et al.Enhanced physical stability and synchronized release of febuxostat and indomethacin in coamorphous solids [J].AAPS PharmSciTech, 2020, 21(2): 41.
[27]
HU Y, GUO Y, LI B, et al.Influence of the pKa value of cinnamic acid and P-hydroxycinnamic acid on the solubility of a lurasidone hydrochloride-based coamorphous system[J].ACS Omega, 2021, 6(4): 3106-3119.
[28]
WU W, GROHGANZ H, RADES T, et al.Comparison of co-former performance in co-amorphous formulations: single amino acids, amino acid physical mixtures, amino acid salts and dipeptides as co-formers [J].Eur J Pharm Sci, 2021,156: 105582.
[29]
RUSSO M G, BALDONI H A, DÁVILA Y A, et al.Rational design of a famotidine-ibuprofen coamorphous system: an experimental and theoretical study [J].J Phys Chem B, 2018, 122(37): 8772-8782.
[30]
SINGH A, VAN DEN MOOTER G.Spray drying formulation of amorphous solid dispersions [J].Adv Drug Deliver Rev, 2016, 100: 27-50.
[31]
ZHANG Y, GAO Y, DU X, et al.Combining co-amorphous-based spray drying with inert carriers to achieve improved bioavailability and excellent downstream manufacturability[J].Pharmaceutics, 2020, 12(11): 1063.
[32]
HIRAKAWA Y, UEDA H, TAKATA Y, et al.Co-amorphous formation of piroxicam-citric acid to generate supersaturation and improve skin permeation [J].Eur J Pharm Sci, 2021,158: 105667.
[33]
OJARINTA R, LERMINIAUX L, LAITINEN R.Spray drying of poorly soluble drugs from aqueous arginine solution [J].Int J Pharm, 2017, 532(1): 289-298.
[34]
BOURDET A, ARAUJO S, THIYAGARAJAN S, et al.Molecular mobility in amorphous biobased copolyesters obtained with 2,5- and 2,4-furandicarboxylate acid [J].Polymer, 2021, 213: 123225.
[35]
PHAN A D, THU THUY T T, KIM AN N T, et al.Molecular relaxations in supercooled liquid and glassy states of amorphous gambogic acid: dielectric spectroscopy, calorimetry, and theoretical approach [J].AIP Adv, 2020,10: 025128..
[36]
YARLAGADDA D L, SAI KRISHNA ANAND V, NAIR A R, et al.Considerations for the selection of co-formers in the preparation of co-amorphous formulations [J].Int J Pharm, 2021, 602: 120649.
[37]
DENGALE S J, GROHGANZ H, RADES T, et al.Recent advances in co-amorphous drug formulations [J].Adv Drug Deliv Rev, 2016, 100: 116-125.
[38]
QIAN S, HENG W, WEI Y, et al.Coamorphous lurasidone hydrochloride−saccharin with charge- assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior [J].Cryst Growth Des, 2015, 15(6): 2920-2928.
[39]
CHEN X, LI D, ZHANG H, et al.Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: a strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis [J].Int J Pharm, 2021, 606: 120894.
[40]
TIAN Y, LIU X, XU L, et al.Engineering crystallinity and oxygen vacancies of Co(II) oxide nanosheets for high performance and robust rechargeable Zn–air batteries [J].Adv Funct Mater, 2021, 31(20): 2101239.
[41]
梅丽,金方.固体分散体表征手段的研究进展[J].中国医药工业杂志,2014,45(8):782-788.
[42]
DAMPF S J, KORTER T M.Crystalline molecular standards for low-frequency vibrational spectroscopies [J].J Infrared Milli Terahz Waves, 2020, 41(11): 1284-1300.
[43]
SZCZUREK J, RAMS-BARON M, KNAPIK-KOWALCZUK J, et al.Molecular dynamics, recrystallization behavior, and water solubility of the amorphous anticancer agent bicalutamide and its polyvinylpyrrolidone mixtures [J].Mol Pharm, 2017,14(4): 1071-1081.
[44]
CHMIEL K, KNAPIK-KOWALCZUK J, JURKIEWICZ K, et al.A new method to identify physically stable concentration of amorphous solid dispersions (I): case of flutamide + Kollidon VA64 [J].Mol Pharm, 2017, 14(10):3370-3380.
[45]
FUNG M H, SURYANARAYANAN R.Effect of organic acids on molecular mobility, physical stability, and dissolution of ternary ketoconazole spray-dried dispersions[J].Mol Pharm, 2019, 16(1): 41-48.
[46]
WILSON V R, LOU X, OSTERLING D J, et al.Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance [J].Sci Rep,2020, 10(1): 18535.
[47]
HU C, ZHANG F, FAN H.Evaluation of drug dissolution rate in co-amorphous and co-crystal binary drug delivery systems by thermodynamic and kinetic methods [J].AAPS PharmSciTech, 2021, 22(1): 21.
[48]
BEVERNAGE J, BROUWERS J, BREWSTER M E, et al.Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues [J].Int J Pharm, 2013,453(1): 25-35.
[49]
KNAPIK-KOWALCZUK J, CHMIEL K, JURKIEWICZ K, et al.Physical stability and viscoelastic properties of co-amorphous ezetimibe/simvastatin system [J].Pharmaceuticals, 2019, 12(1): 40.
[50]
FAEL H, DEMIREL A L.Tannic acid as a co-former in co-amorphous systems: enhancing their physical stability, solubility and dissolution behavior [J].Int J Pharm, 2020,581: 119284.
[51]
HILDEBRAND J H, SCOTT R L.The solubility of nonelectrolytes (3rd ed)[M].New York: Dover Publications, 1964.
[52]
HANSEN C M.The three dimensional solubility parameter and solvent diffusion coefficient [M].Copenhagen: Danish Technical Press, 1967.
[53]
PAJULA K, HYYRYLÄINEN J, KOISTINEN A, et al.Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS [J].Eur J Pharm Biopharm, 2020, 150: 43-49.
[54]
LÖBMANN K, STRACHAN C, GROHGANZ H, et al.Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions [J].Eur J Pharm Biopharm,2012, 81(1): 159-169.
[55]
DI R, LIU J, GROHGANZ H, et al.A multivariate approach for the determination of the optimal mixing ratio of the non-strong interacting co-amorphous system carvedilol-tryptophan [J].Molecules, 2021, 26(4): 801.
[56]
UEDA H, WU W, LÖBMANN K, et al.Application of a salt coformer in a co-amorphous drug system dramatically enhances the glass transition temperature: a case study of the ternary system carbamazepine, citric acid, and L-arginine[J].Mol Pharm, 2018, 15(5): 2036-2044.
[57]
TUREK M, RÓŻYCKA-SOKOŁOWSKA E, KOPROWSKI M, et al.Role of hydrogen bonds in formation of co-amorphous valsartan/nicotinamide compositions of high solubility and durability with anti-hypertension and anti-COVID-19 potential [J].Mol Pharm, 2021, 18(5): 1970-1984.
[58]
HATANAKA Y, UCHIYAMA H, KADOTA K, et al.Improved solubility and permeability of both nifedipine and ketoconazole based on coamorphous formation with simultaneous dissolution behavior [J].J Drug Deliv Sci Tec, 2021, 65: 102715.
[59]
FUNG M H, DEVAULT M, KUWATA K T, et al.Drug-excipient interactions: effect on molecular mobility and physical stability of ketoconazole-organic acid coamorphous systems [J].Mol Pharm, 2018, 15(3): 1052-1061.
[60]
WANG Z, SUN M, LIU T, et al.Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability[J].Asian J Pharm Sci, 2019, 14(1): 95-103.
[61]
UEDA H, PETER BØTKER J, EDINGER M, et al.Formulation of co-amorphous systems from naproxen and naproxen sodium and in situ monitoring of physicochemical state changes during dissolution testing by Raman spectroscopy [J].Int J Pharm, 2020, 587: 119662.
[62]
UEDA H, MURANUSHI N, SAKUMA S, et al.A strategy for co-former selection to design stable co-amorphous formations based on physicochemical properties of non-steroidal inflammatory drugs [J].Pharm Res, 2016, 33(4):1018-1029.
[63]
MOINUDDIN S M, RUAN S, HUANG Y, et al.Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: enhanced physical stability, dissolution and pharmacokinetic profile [J].Int J Pharm,2017, 532(1): 393-400.
[64]
WANG J, CHANG R, ZHAO Y, et al.Coamorphous loratadine-citric acid system with enhanced physical stability and bioavailability [J].AAPS PharmSciTech, 2017, 18(7):2541-2550.
[65]
ZVONÍČEK V, SKOŘEPOVÁ E, DUŠEK M, et al.First crystal structures of pharmaceutical ibrutinib: systematic solvate screening and characterization [J].Cryst Growth Des, 2017, 17(6): 3116-3127.
[66]
SHI X, SONG S, DING Z, et al.Improving the solubility, dissolution, and bioavailability of ibrutinib by preparing it in a coamorphous state with saccharin [J].J Pharm Sci, 2019,108(9): 3020-3028.
2022年第53卷第7期
92
18
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.07.004
  • 接收时间:2021-09-08
  • 首发时间:2026-11-12
  • 出版时间:2022-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-09-08
基金
作者信息
    湖北中医药大学药学院,湖北 武汉 430065

通讯作者:

曹艳(1975—),女,教授,从事中药制剂及新剂型、新技术、新材料的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.07.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏